Page last updated: 2024-11-02

piracetam and Sjogren's Syndrome

piracetam has been researched along with Sjogren's Syndrome in 1 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Sjogren's Syndrome: Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.

Research Excerpts

ExcerptRelevanceReference
"However, dystonia was dramatically improved by a treatment with corticosteroids."1.34Orofacial dystonia related to Sjogren's syndrome. ( Bonakis, A; Kalfakis, N; Kontaxis, T; Papageorgiou, SG, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Papageorgiou, SG1
Kontaxis, T1
Bonakis, A1
Kalfakis, N1

Other Studies

1 other study available for piracetam and Sjogren's Syndrome

ArticleYear
Orofacial dystonia related to Sjogren's syndrome.
    Clinical rheumatology, 2007, Volume: 26, Issue:10

    Topics: Adrenal Cortex Hormones; Brain; Clonazepam; Dystonia; Dystonic Disorders; Face; Female; Humans; Leve

2007